Perrigo Company PLC is a global healthcare company engaged in the manufacture and distribution of private label, over-the-counter pharmaceuticals for a worldwide audience, with around 70% of net sales coming from the U.S. healthcare system. The firm was founded in 1887 and is headquartered in Dublin, Ireland.
The firm is focused on delivering a line of over-the-counter healthcare products, including infant formulas, oral self-care products, and generic pharmaceutical products. Perrigo is the firm behind brands such as Nytol, Niquitin, Bronchostop, Bio-Oil and Jungle Formula. The company is also engaged in the production of licensed formulations on behalf of other healthcare companies and retailers, as well as formulations under the firm’s own brand names, Galpharm and Perrigo.
The firm sells its products primarily in North America and Europe, as well as in other markets, including Australia, Israel, and China. The firm’s brands are sold through merchandisers, supermarkets, drug stores, pharmacies, and e-commerce channels. The firm works in partnership with pharmacists, and offers training seminars, educational kits and CPD modules to support pharmacists in advising consumers regarding over-the-counter solutions. Perrigo is listed on the NYSE under the stock ticker PRGO.
If you are interested in finding out more about PRGO stock add it to your eToro watchlist.